What Makes Life Sciences Transactions M&A Different (Hint: It’s Not Just Specialized Due Diligence)

Our panelists will provide a summary of significant market trends in M&A in the life sciences sector, including a discussion of current legal developments and strategic considerations. The panel will also cover key issues and provisions that are specific to life sciences M&A transactions, including with respect to diligence, IP, representations and warranties, closing conditions, manufacturing, quality and transition services agreements, earn-outs and post-closing integration.

The Morgan Lewis M&A Academy, a 24-part series of tailored webinars led by a diverse team of firm lawyers, provides a comprehensive M&A overview and is ideal for learning about the latest M&A issues and developments. It is geared not only toward M&A professionals but also toward specialists with particular areas of focus (e.g., benefits, intellectual property, tax), whether they deal with M&A issues regularly or occasionally.

For inquiries, please contact Aaisha Khan at aaisha.khan@morganlewis.com.